Acute Termination of Atrial Flutter: Class III Drugs or Transesophageal Pacing?

  • A. Bonso
  • S. Themistoclakis
  • A. Rossillo
  • A. Raviele
Conference paper


Atrial flutter (AFL) is an arrhythmia which occurs frequently. Epidemiological data show an incidence of 88/100 000 new cases per year in the general population in USA, with 200 000 new cases every year [1]. The main predictors of this arrhythmia are heart failure and chronic obstructive pulmonary disease. It often coexists with atrial fibrillation (AF); moreover, it is not unusual that patients undergoing antiarrhythmic treatment with class IC drugs or amiodarone for the treatment of AF develop episodes of AFL. Often AFL is poorly tolerated due to the high ventricular response. This happens even in patients with good control of ventricular rate at rest, who do not tolerate AFL during effort, since ventricular rate increases suddenly.


Atrial Fibrillation Sinus Rhythm Atrial Flutter Paroxysmal Atrial Fibrillation Methane Sulfonamide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Granada J, Uribe W, Cyhou PH et al (2000) Incidence and predictors of atrial flutter in the general population. J Am Coll Cardiol 36:2242–2246PubMedCrossRefGoogle Scholar
  2. 2.
    Natale A, Newby KH, Pisanö E et al (2000) Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol 35:1898–1904PubMedCrossRefGoogle Scholar
  3. 3.
    Bianconi L, Boccadamo R, Pappalardo A et al (1989) Effectiveness of intravenous propafenone for conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am J Cardiol 64:335–338PubMedCrossRefGoogle Scholar
  4. 4.
    Suttorp MJ, Kingma JH, Lie-A-Huen L et al (1989) Intravenous flecainide versus verapamil for conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am J Cardiol 63:693–696PubMedCrossRefGoogle Scholar
  5. 5.
    Antman EM, Beamer Ad, Cantillon C et al (1990) Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs. J Am Coll Cardiol 15:698–707PubMedCrossRefGoogle Scholar
  6. 6.
    Olshansky B (1996) Dofetilide versus quinidine for atrial flutter: vive 1a difference. J Cardiovasc Electrophysiol 7:809–827CrossRefGoogle Scholar
  7. 7.
    Falk RH, Pollak A, Singh SN et al (1997) Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. J Am Coll Cardiol 29:385–390PubMedCrossRefGoogle Scholar
  8. 8.
    Suttorp MJ, Polak PE, Van’t-Hof A et al (1992) Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter. Am J Cardiol 69:417–418PubMedCrossRefGoogle Scholar
  9. 9.
    Bianconi L, Dinelli L, Papalardo A et al (1995) Comparison of intravenously-administered dofetilide vs amiodarone in the acute termination of atrial fibrillation and flutter: a multi-centered randomized, double-blind placebo-controlled study. Circulation 92(Suppl 1):1–775Google Scholar
  10. 10.
    Singh S, Berk M, Zoble R et al (1998) Oral dofetilide for conversion of patients with chronic atrial fibrillation or atrial flutter to normal sinus rhythm: a multicenter study. J Am Coll Cardiol 31 (Suppl A):369A–370ACrossRefGoogle Scholar
  11. 11.
    Ellenbogen KA, Stambler BS, Wood MA et al (1996) Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. J Am Coll Cardiol 28:130–136PubMedCrossRefGoogle Scholar
  12. 12.
    Naccarelli GV, Lee KS, Gibson GK, VanderLugt J (1996) Electrophysiology and pharmacology of ibutilide. Am J Cardiol 78(suppl 8A):12–16PubMedCrossRefGoogle Scholar
  13. 13.
    Stambler BS, Wood MA, Ellenbogen KA et al (1996) Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 94:1613–1621PubMedCrossRefGoogle Scholar
  14. 14.
    Murray KT (1998) Ibutilide. Circulation 97:493–497PubMedCrossRefGoogle Scholar
  15. 15.
    Kowey PR, VanderLugt JT, Luderer JR (1996) Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter. Am J Cardiol 78(Suppl 8A):46–52PubMedCrossRefGoogle Scholar
  16. 16.
    Kowey PR (1997) Use of ibutilide following cardiac surgery. J Am Coll Cardiol 98:633Google Scholar
  17. 17.
    Abi-Mansour P, Carberry PA, McCowan RJ et al (1998) Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Study investigator. Am Heart J 136:632–642PubMedCrossRefGoogle Scholar
  18. 18.
    Haft JL, Kosowsky BD, Lau SH et al (1967) Termination of atrial flutter by electrical pacing of the atrium. Am J Cardiol 20:229CrossRefGoogle Scholar
  19. 19.
    Feld GK, Fleck, Chen PS et al (1992) Radiofrequency catheter ablation for the treatment of human type I atrial flutter: identification of a critical zone in the reentrant circuit by endocardial mapping technique. Circulation 86:1233PubMedCrossRefGoogle Scholar
  20. 20.
    Delia Bella P, Marenzi G, Tondo C et al (1989) Effects of disopyramide on cycle length, effective refractory period and excitable gap of atrial flutter, and relation to arrhythmia termination by overdrive pacing. Am J Cardiol 63:812–816CrossRefGoogle Scholar
  21. 21.
    Olshansky B, Okomura K, Hess PG et al (1988) Use of procainamide with rapid atrial pacing for successful conversion of atrial flutter to sinus rhythm. J Am Coll Cardiol 11:359–364PubMedCrossRefGoogle Scholar
  22. 22.
    Doni F, Delia Bella P, Kheir A et al (1995) Atrial flutter termination by overdrive transesophageal pacing and the facilitating effect of oral propafenone. Am J Cardiol 76:1243–1246PubMedCrossRefGoogle Scholar
  23. 23.
    D’Este D, Bertaglia M, Mantovan R et al (1997) Efficacy of intravenous propafenone in termination of atrial flutter by overdrive transesophageal pacing previously ineffective. Am J Cardiol 79:500–502CrossRefGoogle Scholar
  24. 24.
    Heldal M, Orning OM (1993) Effects of flecainide on termination of atrial flutter by rapid atrial pacing. Eur Heart J 14:421–424PubMedCrossRefGoogle Scholar
  25. 25.
    Stambler BS, Wood MA, Ellenbogen KA (1996) Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing. Am J Cardiol 77:960–966PubMedCrossRefGoogle Scholar
  26. 26.
    Vincenti A, Cirö A, De Ceglia S et al (2001) Predictors of failure of transoesophageal cardioversion of common atrial flutter. Europace 3:10–15PubMedCrossRefGoogle Scholar
  27. 27.
    Chung DC, Kerr CR, Cooper J (1987) Termination of spontaneous atrial flutter by transesophageal pacing. Pacing Clin Electrophysiol 10:1147PubMedCrossRefGoogle Scholar
  28. 28.
    Guarnerio M, Furlanello F, Del Greco M et al (1989) Transesophageal atrial pacing: a first choice technique in atrial flutter therapy. Am Heart J 117:1241PubMedCrossRefGoogle Scholar
  29. 29.
    Kantharia BK, Mookherjee S (1995) Clinical utility and the predictors of outcome of overdrive atrial transesophageal atrial pacing in the treatment of the atrial flutter. Am J Cardiol 76:144–147PubMedCrossRefGoogle Scholar
  30. 30.
    Raviele A, Bonso A, Gasparini G et al (1999) Ibutilide for cardioversion of atrial fibrillation: how effective and safe is it? In: Raviele A (ed) Cardiac arrhythmias. Springer, Milan, pp 186–190Google Scholar
  31. 31.
    Tai CT, Chen SA, Feng AN et al (1998) Electropharmacologic effects of class I and class III antiarrhythmia drugs on typical atrial flutter: insights into the mechanism of termination. Circulation 19:1935–1945CrossRefGoogle Scholar
  32. 32.
    Fera MS, Mazza A, Bettiol F et al (2001) Ibutilide versus transesophageal atrial pacing for atrial flutter treatment. Europace 2(suppl):A17CrossRefGoogle Scholar
  33. 33.
    Rossillo A, Bonso A Themistoclakis S et al (2002) Confronto tra studio elettrofisiologico transesofageo e ibutilide nella riconversione delle aritmie atriali sincronizzate. Ital Heart J 3(suppl): 173SGoogle Scholar

Copyright information

© Springer-Verlag Italia 2004

Authors and Affiliations

  • A. Bonso
    • 1
  • S. Themistoclakis
    • 1
  • A. Rossillo
    • 1
  • A. Raviele
    • 1
  1. 1.Division of Cardiology, Cardiovascular DepartmentUmberto I HospitalMestre-VeniceItaly

Personalised recommendations